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Introduction
In 1985 Meadow and Scott proposed that Berger's dis-
ease could be regarded as Schoenlein-Henoch purpura
without the rash [1]. This assumption is supported by
several features. Glomerular and dermal deposition of
IgA is found in both diseases, and the same types of
glomerular lesions are seen by light microscopy, elec-
tron microscopy and by immunofluorescence [2].
Moreover, patients with nephritis associated with
Schoenlein-Henoch purpura who undergo renal trans-
plantation have recurrence of IgA deposits in the graft
in the absence of extrarenal symptoms, as do patients
with Berger's disease [3]. On the other hand, the
epithelial crescents and glomerular proliferative
changes in patients with SHN were reported to be
more severe than in IgAN [2,4], and the molecular
weight of the immune complexes has been found to be
higher in SHN than in Berger's disease [5]. Moreover,
in childhood, the prognosis of SHN seems to be worse
than that of IgAN [6]. Both IgAN and HSN display
alterations in the proliferation of glomerular cells and
the content or composition of the extracellular matrix
[ECM] compartment leading to fibrosis, sclerosis and
end-stage renal disease [7]. 
In the last decade matrix metalloproteinases
(MMPs) are reported as the most important proteolyt-
ic enzymes involved in remodeling of ECM, and are
crucial for tissue development and homeostasis.
MMPs are classified into six groups based on substrate
and sequence homology. Gelatinases: MMP-2 (gelati-
nase A) and MMP-9 (gelatinase B) cleave the dena-
tured collagens (gelatins) and laminin, as well as some
FOLIA HISTOCHEMICA
ET CYTOBIOLOGICA
Vol. 48, No. 1, 2010
pp. 63-67
Differential glomerular immunoexpression of matrix
metalloproteinases MMP-2 and MMP-9 in idiopathic IgA
nephropathy and Schoenlein-Henoch nephritis 
Marian Danilewicz, Ma³gorzata W¹growska-Danilewicz
Department of Nephropathology (Morphometry Division), Medical University of £ódŸ.
Abstract: Both idiopathic IgA nephropathy (IgAN) and Schoenlein-Henoch nephritis (SHN) are characterized by cell pro-
liferation and abnormal extracellular matrix (ECM) remodeling by mesangial cells leading to fibrosis, sclerosis and end-
stage renal disease. Matrix metalloproteinases MMP-2 and MMP-9 are reported as the most important proteolytic enzymes
involved in remodeling of ECM. Therefore, the aim of the present study was to determine glomerular immunoexpression of
MMP-2 and MMP-9 in IgAN and SHN. Another purpose of this study was to examine the relationship between expression
of MMPs and mesangial cells, a-smooth muscle actin (α-SMA) staining, and monocytes/macrophages. Fifteen patients with
idiopathic IgAN and 12 with SHN were examined by percutaneous renal biopsy. Glomerular staining intensity of MMP-2
and MMP-9 was recorded semiquantitatively, whereas mesangial cells, glomerular α-SMA staining and glomerular CD 68+
cells were assessed quantitatively using computer image analysis system. Our study revealed that the mean values of
glomerular immunoexpression of MMP-2, mesangial cells, α-SMA staining and glomerular CD 68+ cells were in SHN
patients significantly increased as compared to IgAN cases whereas glomerular staining for MMP-9 did not differ in these
groups. Moreover, a glomerular staining of MMP-2 was significantly positively correlated with mesangial cells as well as
glomerular α-SMA staining in both SHN and IgAN. A positive significant correlation between glomerular MMP-2 staining
and glomerular CD68+ cells was noted only in SHN group. The correlations of glomerular MMP-9 and these parameters
were weak and not significant. In conclusion, our results confirm increased glomerular staining of MMP-2 but not MMP-9
in SHN patients. A suggestion that augmented mesangial cells proliferation in these cases depends on MMP-2, α-SMA and
monocytes/macrophages needs further investigations including double staining study. 
Key words: MMP-2, MMP-9, glomerulonephritis
Correspondence: M. Danilewicz, Dept. of Nephropathology
(Morphometry Division), Medical University of £ódŸ, 
Pomorska Str. 251, 92-216 £ódŸ, Poland; 
tel./fax.: (+4842) 6757633, e-mail: hobo@csk.umed.lodz.pl
chemokines [8]. MMP-2 can also activate MMP-1 and
MMP-9 by cleaving their prodomains [9]. Recent
study also demonstrated that gelatinases are involved
in the process of epithelial to mesenchymal transfor-
mation (EMT) in renal tissue [10,11]. The hallmarks of
activation of mesangial as well as tubular cells are de
novo expression of α-smooth muscle actin (α-SMA)
and overproduction of the interstitial matrix compo-
nents [12]. Additionally, it was suggested that during
inflammation monocytes/macrofages may produce
MMP-2 and MMP-9 [6].
Therefore, the aim of the present study was to
determine glomerular immunoexpression of MMP-2
and MMP-9 in IgAN and SHN. Another purpose of
this study was to examine the relationship between
immunoexpression of MMPs and mesangial cells, 
α-SMA staining and monocytes/macrophages.
Materials and methods
Patients. Fifteen patients with idiopathic IgAN (mean age
25.4±9.4) and 12 with SHN (mean age 19.6±8.6) were examined
by percutaneous renal biopsy. For the present study only cases with
diffuse mesangial proliferation were selected. In all cases, diagno-
sis of IgAN and SHN was based on characteristic findings by light
microscopy (sections stained with hematoxylin and eosin, Masson-
Trichrome, Jones' silver impregnation and periodic acid-Schiff fol-
lowed by Alcian Blue) as well as immunofluorescence and elec-
tron-microscopy using standard protocols. Thickness of each sec-
tion was controlled according to the method described by Weibel
[13]. In each case of SHN diagnosis was confirmed clinically.
Clinical features of the patients at the time of biopsy are given in
Table 1. Most of our patients were children and young adults. Male
predominance was noticeable in both IgAN and SHN groups. At
the time of renal biopsy all patients with IgAN and SHN showed
hematuria. Proteinuria accompanied hematuria in 3 IgAN and 5
SHN cases. Clinical renal impairment (serum creatinine greater
than 1.5 mg/dl) was noted only in 2 IgAN patients. Elevated blood
pressure had 2 IgAN and 2 SHN patients.
Immunohistochemistry. Paraffin sections were mounted onto
superfrost slides, deparaffinized, then treated in a microwave oven
in a solution of citrate buffer, pH 6.0 for 20 min and transferred to
distilled water. Endogenous peroxidase activity was blocked by
3% hydrogen peroxide in distilled water for 5 min, and then sec-
tions were rinsed with Tris-buffered saline (TBS, DakoCytoma-
tion, Denmark) and incubated with: monoclonal mouse-anti-
human matrix metalloproteinase-2 (clone 17B11, Novocastra Lab.,
dilution 1:50), monoclonal mouse anti-human matrix metallopro-
teinase -9 (clone 15W2, Novocastra Lab., dilution 1:100), α-SMA
(clone P1b5, DakoCytomation, Denmark, dilution 1:50), and mon-
oclonal mouse anti-human CD68 antibody (DakoCytomation,
Denmark, dilution 1:100). Afterwards LSAB+/HRP Universal kit
(DakoCytomation, Denmark) prepared according to the instructions
of the manufacturer was used. Visualisation was performed by incu-
bating the sections in a solution of 0.5 mg 3,3'-diaminobenzidine
(DakoCytomation, Denmark), per ml Tris-HCl buffer, pH 7.6, con-
taining 0.02% hydrogen peroxide, for 10 min. After washing, the
sections were counter-stained with hematoxylin and coverslipped.
For each antibody and for each sample a negative control were
processed. Negative controls were carried out by incubation in the
absence of the primary antibody and always yielded negative results. 
In each specimen staining intensity of MMP-2 and MMP-9
was recorded in all glomeruli semiquantitatively by two independ-
ent observers and graded from 0 (staining not detectable), 1 (weak
diffuse staining with only focally increased mesangial staining), 2
(mild staining with focally strong mesangial staining) and 3 (strong
staining of the glomerular tuft). The mean grade was calculated by
averaging grades assigned by the two authors and approximating
the arithmetical mean to the nearest unity.
Morphometry. Histological morphometry was performed by
means of image analysis system consisting of a PC computer
equipped with a Pentagram graphical tablet, Indeo Fast card (frame
grabber, true-color, real-time), produced by Indeo (Taiwan), and
color TV camera Panasonic (Japan) coupled to a Carl Zeiss micro-
scope (Germany). This system was programmed (MultiScan 8.08
software, produced by Computer Scanning Systems, Poland) to
calculate the number of objects (semiautomatic function) and the
surface area of a structure using stereological net (with regulated
number of points). The coloured microscopic images were saved
serially in the memory of a computer, and then quantitative exam-
inations had been carried out. 
Alpha-SMA staining per cent of total glomerular area was
measured using point counting method which is an adaptation of
the principles of Weibel [13]. The point spacing being 16 μm. Total
numbers of the points of a net was 169, and total area was 36864
sq.μm. The percentage of α-SMA staining was an expression of the
number of points overlying these structures as a percentage of the
total points counted. 
Glomerular monocytes/macrophages were determined by
counting CD68+ cells (semiautomatic function). Only immunore-
active cells with the clear identifiable nucleus were counted. Cells
were scored positive when displayed a distinctly brown membrane.
Extracapillary cells, such as in crescents, where present, were
excluded from the count of intraglomerular immune cells. The
number of positive cells per glomerular cross-section in each sec-
tion was obtained and used in the analysis. The same method was
used to determine mesangial cells in sections stained with period-
ic acid-Schiff followed by Alcian Blue).
Statistical analysis. Differences between groups were tested using
unpaired Student's t-test preceded by evaluation of normality and
Levene's test. The Mann-Whitney U test was used where appropri-
ate. Correlation coefficient was calculated using Spearman's method.
Results were considered statistically significant if p<0.05.
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Table 1. Clinical findings at the time of biopsy in cases with IgAN and SHN.
Values in the table are number of cases. 1Serum creatinine >1.5 mg/dl
Results
In IgAN and SHN glomerular staining for both MMP-
2 and MMP-9 were found mainly in the mesangial
regions and in some periglomerular cells (Fig. 1-4).
Additionally weak staining was noted in the tubular
epithelial cells and focally in the interstitium, but in
the present study this extraglomerular immunoexpres-
sion of MMP-2 and MMP-9 was not taken into con-
sideration. 
A morphometric and semiquantitative compari-
son of glomerular parameters in cases with IgAN and
SHN appear from Table 2. The mean values of
glomerular immunoexpression of MMP-2, mesangial
cells, α-SMA staining and glomerular monocytes/
macrophages were in SHN patients significantly
increased as compared to IgAN cases whereas
glomerular staining for MMP-9 did not differ in these
groups. Moreover, a glomerular immunoexpression
of MMP-2 was significantly positively correlated
with mesangial cells as well as glomerular α-SMA
staining in both SHN and IgAN (Table 3). On the
other hand, a positive significant correlation between
glomerular MMP-2 staining and glomerular mono-
cytes/ macrofages was noted only in SHN group. The
correlations of glomerular MMP-9 staining and these
parameters were weak and not significant.
Discussion
Both IgAN and SHN are characterized by cell prolif-
eration and abnormal ECM remodeling by mesangial
cells [14]. Glomerular mesangial cells are embedded in
the mesangial matrix and control its turnover through a
dynamic equilibrium between synthesis and degrada-
tion [15]. The regulation of ECM remodeling in the
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Fig. 1. Weak mesangial immunoexpression of MMP-2 in kidney biopsy in patient with IgAN. Immunostaining with antibody against
MMP-2 (original magnification ×400). Fig. 2. Moderate immunoexpression of MMP-2 in kidney biopsy in patient with SHN. Immunos-
taining with antibody against MMP-2 (original magnification ×400). Fig. 3. Strong immunoexpression of MMP-9 in kidney biopsy in
patient with IgAN. Immunostaining with antibody against MMP-9 (original magnification ×400). Fig. 4. Similarly like in IgAN intense
mesangial staining for MMP-9 can be seen in patient with SHN. Immunostaining with antibody against MMP-9 (original magnification
×400).
kidney by MMPs has previously been studied by use of
models of interstitial fibrosis and glomerular sclerosis
[16,17]. However, there are only a few reports examin-
ing the role of MMPs in human glomerulonephritis
[14] and glomerular immunolocalisation of MMP-2
and MMP-9 is still a matter of controversies. Sanders et
al. [18] found in human ANCA-associated glomeru-
lonephritis immunoexpression of MMP-2 in glomeru-
lar and periglomerular cells whereas in study of Urushi-
hara et al.. [14] immunoreactvities to MMP-2 were not
detected on glomerular tufts in controls or in patients
with any types of glomerulonephritis. It is noteworthy
that this latter study included also 20 patients with
IgAN and 4 with SHN. In contrast to Urushihara et al.
[14] we revealed immunoexpression of MMP-2 in the
mesangial regions and in some periglomerular cells in
all IgAN and SHN patients. On the other hand, similar-
ly like these authors, we found strong glomerular
immunoexpression of MMP-9 in both groups investi-
gated. The glomerular immunolocalisation of MMP-9
was the same as MMP-2. Interestingly, Sanders et al.
[18] found in ANCA-associated glomerulonephritis
immunoexpression of MMP-9 only in glomeruli with
active crescents.
Our study revealed significantly increased
glomerular immunoexpression of MMP-2 but not
MMP-9 in SHN group as compared with IgAN
patients. These two gelatinases have ability to break-
down components of the basement membrane and col-
lagens, and in vitro both enzymes have a very similar
substrate profile [19]. Matrix-degrading enzymes are
historically considered to reduce matrix accumulation,
thereby attenuating renal fibrosis after injury. Howev-
er, recent genetic studies using knock-out mice have
painted a different and complex picture of the function
of these proteins in relation to fibrotic lesions in vivo
[10-12]. The biologic role of MMP-2 was first ana-
lyzed in cultured rat mesangial cells [20,21]. In these
cells, the constitutive synthesis of MMP-2 was almost
completely inhibited. The noticeable differences
included changes in synthesis of ECM proteins, loss of
the activation marker α-SMA and almost total arrest of
cell proliferation. The direct effect of MMP-2 on
mesangial cell proliferation was latter confirmed in
vivo, since infusion of activated MMP-2 into renal
artery demonstrated focal areas of mesangial cell pro-
liferation in rat glomeruli [21,22]. In the present study
not only MMP-2 but also mesangial cells were signif-
icantly increased in SHN group as compared to IgAN
patients. Moreover, our correlative study on MMP-2
discovered in both IgAN as well as SHN groups sig-
nificant positive correlations between glomerular
immunoexpression of MMP-2 and mesangial cells.
These results are in agreement with observations of
others authors [21-23] that MMP-2 play a crucial role
in proliferation of the mesangial cells. In addition, sig-
nificant positive correlation existed in these groups
between glomerular immunoexpression of MMP-2
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Table 2. A morphometric and semiquantitative comparison of glomerular parameters in cases with IgAN and SHN. Data are expressed as
mean ±SD.
Table 3. Spearman rank order correlations between glomerular immunoexpression of MMPs and mesangial cells, α-SMA as well as
monocytes/macrophages in patients with IgAN and SHN
and glomerular α-SMA staining. This result support
previous observations [20] that MMP-2 is required for
-smooth muscle actin positive mesangial cell pheno-
type and presumably play an important role in ECM
remodeling during the development of mesangial
injury. Furthermore, Sanders et al. [18] documented
that in ANCA-associated glomerulonephritis MMP-2
positive mesangial cells were also α−SMA positive. 
In SHN patients significant positive correlation was
noted between glomerular immunoexpression of MMP-
2 and glomerular monocytes/macrophages. In IgAN
group this correlation was also positive, but it did not
reach statistical significance. Monocytes/macrophages
are important effector cells in both the adaptive and the
innate immune response and their accumulation is a
prominent feature in most types of human glomeru-
lonephritis [24]. There is a wide range of factors poten-
tially secreted by stimulated CD 68+ cells, such as
cytokines, growth factors and metalloproteinases [25].
Double labeling study clarified that CD 68 positive
macrophages produced MMP-2 [18]. Our correlative
study on MMP-2 and CD68+ cells seems to be in con-
cordance with these findings, however we are aware that
a morphometric analysis does not lend itself to establish
such casual associations.
Finally, we found strong glomerular immunoex-
pression of MMP-9 but it did not differ significantly in
IgAN and SHN groups. As correlations between
MMP-9 and mesangial cells, α -SMA staining and CD
68+ cells were also weak and not significant, the role
of this gelatinase in activation of mesangial cells
seems to be uncertain in both IgAN and SHN groups.
In conclusion, our results confirm increased
glomerular staining of MMP-2 but not MMP-9 in SHN
patients. A suggestion that augmented mesangial cells
proliferation in these cases depends on MMP-2, α-
SMA and monocytes/macrophages needs further
investigations including double staining study.
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